Top 5 Growth Strategies in the Tissue Diagnostics Market: Forecast 2023–2033

 According to a research report published by Spherical Insights & Consulting, The Global Tissue Diagnostics Market Size Expected to Grow from USD 4.9 Billion in 2023 to USD 10.8 Billion by 2033, at a CAGR of 8.22% during the forecast period 2023-2033.

Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/4590

Tissue diagnostics includes examining tiny samples of body tissues to recognize diseases such as cancer. The samples are then analyzed under a microscope for abnormal cells or structures. Tissue diagnostics is a crucial tool for the detection, monitoring, and management of different cancer cases. Identification of disease signs and symptoms is accomplished by biopsies, which include taking a sample from a site of interest, such as skin, tissue, or a tumor. Numerous ailments, including cancer, viral diseases, autoimmune disorders, and hereditary disorders, are being evaluated and diagnosed by it. Tissue diagnostics help physicians make precise diagnoses and choose the best treatment plan for their patients. Furthermore, histology, immunohistochemistry, in situ hybridization, cytogenetics, and molecular pathology are some of the techniques and instruments utilized in tissue diagnosis. The usage of digital pathology systems by medical professionals worldwide has increased as a result of the ongoing trend of automation of diagnostic laboratory activities in major healthcare markets. However, the FDA’s current tissue diagnostic equipment and supply approval process is a major obstacle for businesses looking to introduce innovative goods.

Browse key industry insights spread across 273 pages with 110 Market data tables and figures & charts from the report on the Global Tissue Diagnostics Market Size, Share, Growth Analysis, By Product (Consumables and Instrument), By Technology (Immunohistochemistry (IHC), In Situ Hybridization (ISH), Digital Pathology & Workflow, and Special Staining), By Application (Breast Cancer, Prostate Cancer Gastric Cancer, and Other), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Buy Now Full Report: https://www.sphericalinsights.com/checkout/4590

The consumables segment is expected to hold the greatest market share over the forecast period.

On the basis of the product, the global tissue diagnostics market is divided into consumables and instruments. Among these, the consumables segment is expected to hold the greatest market share over the forecast period. This is attributed to the increased R&D expenditures by leading pharmaceutical companies and more public and private financing for life sciences and cancer research are expected to fuel this segment’s growth.

The immunohistochemistry (IHC) segment is expected to grow at a rapid CAGR growth over the forecast period.

On the basis of the technology, the global tissue diagnostics market is divided into Immunohistochemistry (IHC), in situ hybridization (ISH), digital pathology & workflow, and special staining. Among these, the immunohistochemistry (IHC) segment is expected to grow at a rapid CAGR growth over the forecast period. This is attributed to the IHC tests for particular antigens in tissue using antibodies by combining immunological, anatomical, and biochemical methods. High-specificity antibodies are used to attach to and identify antigens. This method is widely used for the diagnosis of abnormal cells.

The breast cancer segment accounted for the largest revenue share through the forecast period.

On the basis of the application, the global tissue diagnostics market is divided into breast cancer, prostate cancer, gastric cancer, and others. Among these, the breast cancer segment accounted for the largest revenue share through the forecast period. This is attributed to the detection, diagnosis, and treatment planning of breast cancer, a significant worldwide health issue, that depends on tissue diagnostics. More and more research is being done on breast tissue samples using sophisticated methods like immunohistochemistry and in situ hybridization to accurately describe tumors.

Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/4590

North America is expected to hold the largest share of the global tissue diagnostics market throughout the predicted timeframe.

North America is expected to hold the major share of the global tissue diagnostics market throughout the predicted timeframe. Numerous government initiatives are underway to lower the number of cancer cases and raise the demand for cancer diagnosis in the area. To prevent cancer in that area, the Centers for Disease Control and Prevention launched a groundbreaking project called the Cancer Prevention and Control Research Institute. Due to the significant growth of tailored medicine brought about by the rising use of healthcare systems and sequencing technologies in clinical workflow, tissue diagnostics are being used more frequently. The precision medicine movement in the US is helping to propel the growth of the personalized medicine industry in North America.

Asia Pacific is anticipated to grow at a rapid CAGR growth of the global tissue diagnostics market through the forecast period. The Asia-Pacific area is expected to grow at a lucrative pace throughout the projected period due to the increased use of many tissues diagnostic assays provided by international companies.

Major vendors in the global tissue diagnostics market F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens, Danaher, bioMérieux SA, QIAGEN, Merck KGaA, GE Healthcare, BioGenex, Cell Signaling Technology, Inc., Bio SB, DiaGenic ASA, Agilent Technologies, and others.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 Key Market Development

• In July 2023, AmeriPath, a new tissue-based prostate cancer biomarker test, was introduced by Quest Diagnostics through its subspecialty pathology division. The firm claims that it worked with Envision Sciences, a company based in Australia, to develop the new tissue-based test. It aims to meet the urgent clinical need for diagnostics that can assist in identifying and distinguishing between men’s prostate cancer cases that may be aggressive.
• In June 2023, In Marana, Roche Tissue Diagnostics is expanding into the manufacturing of cancer-detecting equipment and tests by building a 60,000-square-foot facility adjacent to an existing distribution center. All instrument manufacturing activities will be housed in the new complex, which will replace Roche’s main campus in Oro Valley.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global tissue diagnostics market based on the below-mentioned segments:

Global Tissue Diagnostics Market, By Product  

• Consumables
• Instrument

 Global Tissue Diagnostics Market, By Technology

• Immunohistochemistry (IHC)
• In Situ Hybridization (ISH)
• Digital Pathology & Workflow
• Special Staining

 Global Tissue Diagnostics Market, By Application

• Breast Cancer
• Prostate Cancer
• Gastric Cancer
• Other

Global Tissue Diagnostics Market, By Region

• North America
  • US
  • Canada
  • Mexico

• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

Browse Related Reports:

Global Renal Denervation Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Symplicity, Enlightn, Vessix, Paradise, Iberis, Others), by Technology (Radiofrequency, Ultrasound, Micro-Infusion), by End User (Hospitals, Specialty Clinics, Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

Global Sterile Bioprocess Filtration Market Size, Share, and COVID-19 Impact Analysis, By Product (Membrane Filters, Depth Filters, Cartridge Filters, Capsule Filters, Filtration Accessories, and Others), By End User (Biopharmaceutical & Biotechnology Companies, CMOs & CROs, and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033.

Global C3 Glomerulopathy Market Size, Share, and COVID-19 Impact Analysis, By Type (C3 Glomerulopathy, Atypical Hemolytic-Uremic Syndrome, and Complement Mediated Kidney Disease), By End User (Hospitals, Specialty Clinics, and Research Institutes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

Global Throat Lozenges Market Size, Share, and COVID-19 Impact Analysis, By Type (Hard Candy Lozenges, Soft Lozenges, And Compressed Lozenges), By Ingredient (Menthol, Mint, Eucalyptus Oil, Peppermint Oil, Honey & Ginger, Lemon, and Others), By Indication (Sore Throat, Cough and Cold, and Throat Diseases), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 – 2035.

About Spherical Insights & Consulting

Spherical Insights & Consulting is a leading market research and consulting firm providing actionable insights, quantitative forecasting, and trend analysis to support business decision-making. The firm serves industries such as finance, government, industrial sectors, and corporations, helping them achieve strategic growth.

Contact Us:

📞 US: +1 303 800 4326

📞 APAC: +91 90289 24100

📧 Email: inquiry@sphericalinsights.com | sales@sphericalinsights.com

🌐 Website: Contact Us

📌 Follow Us: LinkedIn | Facebook | Twitter